PI3-kinase activity modulates apo B available for hepatic VLDL production inapobec-1−/−mice
Authors:
- Nicholas O. DavidsonNDNicholas O. Davidson
- Charles E. SparksCSCharles E. Sparks
- Janet D. SparksJSJanet D. Sparks
- 1 September 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 291 (3) , G382-G388
Abstract
Insulin regulates hepatic VLDL production by activation of phosphatidylinositide 3-kinase (PI3-kinase) which decreases apo B available for lipid assembly. The current study evaluated the dependence of the VLDL apolipoprotein B (apo B) pathway on PI3-kinase activity in vivo. VLDL production was examined in B100 only, apo B mRNA editing catalytic subunit 1 ( apobec-1−/−) mice, using the Triton WR 1339 method. Glucose injection suppressed VLDL triglyceride production by 28% in male and by 32% in female mice compared with saline-injected controls. When wortmannin was injected to inhibit PI3-kinase, VLDL triglyceride production was increased by 52% in males and by 89% in females, and VLDL B100 levels paralleled triglyceride changes. Pulse-chase experiments in primary mouse hepatocytes showed that wortmannin increased net freshly synthesized B100 availability by >35%. To test whether physiological insulin resistance produced equivalent effects to wortmannin, we studied male apobec-1−/−mice who became hyperlipidemic on being fed a fructose-enriched diet. Fructose-fed apobec-1−/−mice had significantly higher VLDL triglyceride and B100 production rates compared with chow-fed mice, and rates were refractile to glucose or wortmannin. Hepatic VLDL triglyceride and B100 production in wortmannin-injected chow-fed mice equaled that observed in fructose-fed mice. Together, results suggest in vivo and in vitro that wortmannin-sensitive PI3-kinases maintain a basal level of VLDL suppression that is sensitive to changes in activation and that can increase VLDL production when PI3-kinase is inhibited to levels similar to those induced by insulin resistance.Keywords
This publication has 38 references indexed in Scilit:
- Hepatic secretion of small lipoprotein particles in apobec-1−− mice is regulated by the LDL receptorJournal of Lipid Research, 2004
- Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Translational Control of Apolipoprotein B mRNA: Regulation via Cis Elements in the 5‘ and 3‘ Untranslated RegionsBiochemistry, 2004
- Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesisBiochemistry and Cell Biology, 2004
- Identification and Regulation of Protein Components of the Apolipoprotein B mRNA Editing Enzyme A Complex EventTrends in Cardiovascular Medicine, 2002
- Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin ResistanceJournal of Biological Chemistry, 2002
- The Triple Threat to Nascent Apolipoprotein BJournal of Biological Chemistry, 2001
- Chemokine Receptors: Cloning StrategiesMethods, 1996
- Targeted Disruption of the Mouse apobec-1 Gene Abolishes Apolipoprotein B mRNA Editing and Eliminates Apolipoprotein B48Journal of Biological Chemistry, 1996
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970